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Abstract
The growing applications of carbon nanotubes (CNTs) inevitably increase the risk of exposure to
this potentially toxic nanomaterial. In an attempt to address this issue, research has been
implemented to study the biodegradation of CNTs. In particular, myeloperoxidase (MPO), an
enzyme expressed by inflammatory cells of animals including humans, catalyse the degradation of
oxidized carbon nanomaterials. While reactive intermediates generated by MPO efficiently
degrade oxidized single-walled carbon nanotubes (o-SWCNTs); the exact mechanism of enzyme-
catalysed biodegradation remains ambiguous. In this work, we tried to explain enzymatic
oxidation in terms of redox potentials by employing competitive substrates for MPO such as
chloride, which is oxidized by MPO to form a strong oxidant (hypochlorite), and antioxidants that
have lower redox potentials than CNTs. Employing transmission electron microscopy, Raman
spectroscopy, and vis-NIR absorption spectroscopy, we demonstrate that the addition of
antioxidants, L-ascorbic acid and L-glutathione, with or without chloride significantly mitigates
MPO-catalysed biodegradation of o-SWCNTs. This study focuses on a fundamental understanding
of the mechanisms of enzymatic biodegradation of CNTs and the impact of antioxidants on these
pathways.
Introduction
Over the past 20 years, the unique electronic,1 optical,2 and mechanical3 properties of
carbon nanotubes (CNTs) have fuelled extensive, ground breaking research in areas such as
electronics,4 sensors,5,6 composite materials,7 and energy conversion devices.8 The full
commercial potential of CNTs may not be realized, however, as a consequence of the
possible pro-inflammatory and toxic effects of these carbon nanomaterials.9–13 There exists
a risk of human exposure as a result of either occupational or environmental exposure (i.e. as
products fabricated from CNTs degrade from wear over time). Since CNT contamination
may induce a robust inflammatory response and severe oxidative stress that results in tissue
damage,14 it is necessary to address issues relating to CNT distribution/transformation,
toxicity, and persistence.15–19 To answer some of these questions, fundamental studies
demonstrated that the plant enzyme, horseradish peroxidase (HRP),20–25 and
myeloperoxidase (MPO),25–28 an enzyme expressed by inflammatory cells in animals
†Electronic supplementary information (ESI) available: Full experimental details, including: Raman spectra, vis-NIR absorption data,
absorption vs. antioxidant concentration plots, EPR studies, and ESI-MS spectra, degradation experiments with antioxidant-treated o-
SWCNTs, and MPO activity assay. See DOI: 10.1039/c2tb00047d
Correspondence to: Alexander Star, astar@pitt.edu.
NIH Public Access
Author Manuscript
J Mater Chem B Mater Biol Med. Author manuscript; available in PMC 2014 January 01.
Published in final edited form as:













including humans, catalysed the degradation of oxidized carbon nanomaterials. In the case
of the physiologically relevant enzyme, MPO, it has been established both in vitro26,27,29
and in vivo,28–30 that MPO catalysed the biodegradation of carbon nanomaterials thus
decreasing the damage associated with CNT exposure. The exact mechanism of enzyme-
catalysed biodegradation remains ambiguous; it has been hypothesized that the type of
defects (i.e. types of functional groups), enzyme–CNT interactions, and relative oxidative
strength of the enzymatic system/generated oxidant vs. the CNT contribute to the
degradation process.25 In this work, we studied the effect of two water-soluble antioxidants,
L-ascorbic acid (AA) and L-glutathione (GSH), on MPO-catalysed biodegradation of o-
SWCNTs with and without Cl− (Fig. 1). The antioxidants were selected because they
possess a lower redox potential than o-SWCNTs and therefore are more favourably oxidized
by the enzymatic system.
Antioxidants serve as a natural defence system whereby cells are protected from reactive
intermediates and oxidants (i.e. ‘‘oxidative stress’’).31 L-Ascorbic acid (vitamin C, AA),
which is a six-carbon lactone derived from glucose by plants and most animals, functions as
a scavenging water-soluble antioxidant that donates electrons sequentially resulting in the
formation of the ascorbate radical and dehydroascorbic acid (DHA), respectively.32 AA
mitigates lipid peroxidation by both scavenging reactive oxygen species (ROS) and via the
vitamin E redox cycle.33 A second important endogenous water-soluble tripeptide
antioxidant, L-glutathione (L-γ-glutamyl-L-cysteinylglycine, GSH), derives its antioxidant
function from the thiol functional group (–SH) belonging to its cysteine residue.34 While the
oxidized dimer of GSH, glutathione disulphide (GSSG), represents the hallmark of oxidative
stress, the enzyme, glutathione reductase, maintains glutathione primarily in its reduced
active form (i.e. GSH).34
Myeloperoxidase (MPO), a heme-containing enzyme, is primarily expressed in
polymorphonuclear cells (PMNs) of animals including humans.35–37 Upon activation, these
inflammatory cells release MPO from intracellular granules,35 where this enzyme exists in
millimolar (mM) concentrations,38 to either intraphagosomal or extracellular spaces. MPO is
subsequently oxidized by H2O2 from its Fe(III) resting state to MPO-Compound I, and in
the presence of chloride (Cl−, 80 mM for PMNs and 140 mM in plasma),38 which represents
a competitive substrate for the enzyme, MPO-Compound I is reduced back to the ferric
resting state during which Cl− undergoes a two-electron oxidation to form hypochlorous
acid (HOCl, Fig. 1). This oxidant, which has a pKa of 7.6,35 exists as both HOCl and the
hypochlorite ion (−OCl) at physiological pH (i.e. 7.4). Moreover, with a high redox potential
of 1.48 V,39 HOCl indiscriminately oxidizes invading bacteria and biologically significant
macromolecules; therefore, HOCl is integral to the innate immunity35 in the former case and
contributes to oxidative stress in the latter scenario. Because hypochlorite has the ability to
introduce acid ‘‘defects’’ onto the surface of CNTs40 and MPO catalyses the biodegradation
of these carbon nanomaterials,26,27 acquiring further insight into the mechanism of
biodegradation will potentially provide new understanding of the distribution/
transformation, toxicity, and persistence of CNTs.
Results and discussion
Transmission electron microscopy (TEM)
o-SWCNTs that contained carboxylic acids between 1.0 and 3.0 atomic%41 and were
initially around 1 μm in length (Fig. 2a) were incubated at 37 °C with MPO and H2O2 for
four days in the presence and absence of Cl−, and the samples were inspected by
transmission electron microscopy (TEM). In the presence of Cl−, the micrographs display
only residual carbonaceous material thereby marking the absence of tubular structures and
indicating biodegradation (Fig. 2b). TEM micrographs in the absence of Cl− denote the
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presence of shortened nanotubes and carbonaceous material (not shown). Next, the initial
system was supplemented with either AA or GSH (1 mM per addition) during a four day
time course at 37 °C. Significantly, in the presence of Cl−, the TEM micrographs indicate
that both antioxidants preserve the nanotubes’ cylindrical structures, and most of the
nanotubes exist on the grid as large aggregates (Fig. 2c and d). This observation is likewise
noted for the system without Cl− and with antioxidants (not shown).
Raman spectroscopy
The data obtained from Raman spectroscopy reinforces the TEM observations. For o-
SWCNTs, distinct peaks are noted for the radial breathing mode (RBM, 147 cm−1 and 159
cm−1), D (1348 cm−1), G (1592 cm−1) and 2D (2643 cm−1) bands (Fig. 3a, blue curve),42
and o-SWCNTs possess a D/G ratio of 0.53. For the MPO–H2O2 system with Cl−, there is
an absence of the characteristic Raman signature that is indicative of SWCNTs, however,
thereby signifying that the o-SWCNTs are completely biodegraded (Fig. 3a, green curve).
For enzymatic conditions without Cl−, the RBM and D, G, and 2D bands are observed
demonstrating the presence of o-SWCNTs (Fig. 3b and ESI†); the RBM and 2D bands,
however, are stifled relative to the spectrum for o-SWCNTs. Moreover, the D/G ratio
increased from 0.53 to 0.65 as a result of o-SWCNT biodegradation by reactive
intermediates. This increase in the D band is indicative of increased disorder in the sp2-
hybridized carbon system.42 Finally, with the retention of the RBM and D, G, and 2D bands,
the Raman signatures for o-SWCNTs treated with either anti-oxidant and with or without
Cl− mirror that of o-SWCNTs (Fig. 3a and ESI†) and provide further indication that the
nanotube structure is conserved in the presence of antioxidants.
Examining the RBM provided additional insight into the mechanism of o-SWCNT
biodegradation. Given that a laser with a 633 nm wavelength was employed, the resonant
Raman scattering signals was primarily obtained from metallic nano-tubes because the
energy of the M11 optical transition is close to the energy of the photon generated by the
laser.43 Initially at day 0, two main peaks at 159 cm−1 and 147 cm−1 were observed (Fig.
3b). These peaks can be assigned to metallic o-SWCNTs with calculated diameters around
1.41 and 1.52 nm, respectively, when using the equation, ωr = 223.75 (cm−1 nm)/d (nm).
Under Cl− conditions, all of the nanotubes, regardless of chirality, appeared to degrade, and
no RBM features remained after one day (Fig. 3b). In the absence of Cl−, the biodegradation
resulting from reactive intermediates proceeded at a slower rate as evidenced by
examination of the RBM (Fig. 3b). The remaining peak was centred at 170 cm−1, which may
be attributed to an upshift in the RBM for the 1.41 nm diameter o-SWCNTs by ~11 cm−1.
This upshift, which results from a decrease in the energy spacing between van Hove
singularities,43 could be explained by either enzymatic selectivity for larger diameter
nanotubes or further oxidation of the o-SWCNTs by the reactive intermediates of MPO.
Such an upshift has been documented in the literature for the RBM of o-SWCNTs versus as
prepared SWCNTs;43–46 however, there exist conflicting explanations regarding the cause
of this observation.
Vis-NIR absorption spectroscopy
The vis-NIR absorption spectrum of o-SWCNTs demonstrates distinct characteristic S22 and
M11 transitions (Fig. 3c, blue curve, and inset); after four days under enzymatic/peroxide
conditions and in the presence of Cl−, however, the S22 and M11 transitions are severely
subdued (Fig. 3c, red curve), which is indicative of biodegradation. Given the equal
concentrations of o-SWCNTs, degradation was quantified by integrating the S22 peak
relative to the baseline (ESI†). The S22 peak area for o-SWCNTs in the presence of Cl− was
reduced 4.1 times compared to o-SWCNTs. In the absence of Cl−, retention of the S22 and
M11 transitions is apparent albeit subdued (ESI†), which is demonstrated by the reduction of
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S22 peak area of only 2.7 times. This result is consistent with the TEM and Raman data,
which indicate that the o-SWCNTs are degrading at a slower rate via reactive intermediates.
The absorption spectra for o-SWCNTs incubated with MPO/H2O2, either antioxidant, and in
the presence and absence of Cl− demonstrate the retention of the S22 and M11 bands thereby
signifying the presence of o-SWCNTs (Fig. 3c and ESI†). In the presence of Cl−, the ratios
of the S22 peak areas are 0.77 and 1.0 for o-SWCNTs relative to AA and GSH treated o-
SWCNTs, respectively, and 0.84 and 1.1, respectively, in the absence of Cl−.
Finally, a microplate reader was employed to obtain high throughput absorption readings at/
near the S22 absorption transition for multiple samples and controls, and the resulting data
further corroborated the results obtained by TEM and both Raman and vis-NIR
spectroscopies. It is worth noting that in the range of 800 nm and 1300 nm, the scattering
effect of CNTs is minimal (i.e. <8%);47 therefore, >92% of the signal obtained for the S22
band is derived from CNT absorption. Fig. 3d portrays a 75% and 60% decrease in the S22
absorption intensity at day 4 relative to day 0 in the presence and absence of Cl−,
respectively. On the other hand, the controls for o-SWCNTs declined by an insignificant
amount over the same time period (Fig. 3d and ESI†). Fig. 3d also demonstrates a minimal
decline in S22 absorption intensity at day 4 relative to day 0 for AA or GSH with and
without chloride. Therefore, both antioxidants significantly suppressed both hypochlorite-
induced biodegradation and degradation resulting from reactive intermediates generated by
the peroxidase cycle (Fig. 1). We also compared the effects of changing antioxidant
concentrations on o-SWCNT degradation as measured by the relative change in S22
absorption in both the presence and absence of Cl− (ESI†). Lower concentrations of
antioxidants (~200 μM for AA and ~50 μM for GSH) per additions demonstrated the same
level of protection against HOCl afforded by 1 mM additions of either AA or GSH.
Additional characterization techniques
Electron paramagnetic resonance (EPR) spectroscopy and positive mode electrospray
ionization-mass spectrometry (ESI-MS) were employed to qualitatively confirm the
oxidation of AA and GSH, respectively, under chloride conditions. EPR spectroscopy
confirmed the formation of the ascorbate radical after 1 h incubation under experimental
conditions (ESI†). Moreover, in the presence of Cl−, glutathione sulphonic acid (GSO2OH)
and glutathione disulphide (GSSG) were observed at a m/z of 356 and 613, respectively,
utilizing ESI-MS (ESI†).
Potential mechanism – why is HOCl more efficient at biodegradation than reactive
intermediates?
As previously demonstrated, both samples, which consisted of o-SWCNTs that were
incubated at 37 °C with MPO and H2O2 for four days in the presence and absence of Cl−,
degraded;7 the degree of degradation, however, was dependent on the strength of the
oxidant. HOCl is produced in the presence of chloride (Fig. 1) and possesses a redox
potential of 1.48 V, which is greater than the mean redox potential for the reactive
intermediates of MPO (E0 = 1.16 V) that form during the peroxidase cycle (i.e. in the
absence of chloride, Fig. 1).25 Consequently, as demonstrated in Fig. 4a, both species are
able to oxidize SWCNTs (E0 = 0.5 V).25 Compared to HOCl induced degradation, however,
o-SWCNTs biodegradation catalysed via reactive intermediates was less efficient as
demonstrated by the TEM, Raman spectroscopic, and vis-NIR spectroscopic data. Molecular
simulations studies provide a second possible justification for the lower biodegradation
efficacy of reactive intermediates.26 When dispersed in an aqueous media at physiological/
experimental pH (i.e. pH = 7.4), the carboxyl groups of the o-SWCNTs, which have a pKa
of approximately 5.5,48 will be deprotonated as demonstrated by a zeta potential of
approximately −50 mV.49 Additionally, with an isoelectric point greater than 10,50 MPO
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will be protonated and highly cationic at pH 7.4. Therefore, to degrade o-SWCNTs
employing reactive intermediates, the negatively charged carboxyl groups of o-SWCNTs
must interact with the positively charged arginine residues of MPO via electrostatic
interactions in such a fashion that the nanotube is properly oriented towards and in close
enough proximity to the proximal end of the heme group, which involves the catalytically
active tyrosine residues, Tyr 293 and 313.26 It is hypothesized that these radical supporting
aromatic residues catalysed the cleavage of o-SWCNTs.26 On the other hand, in the
presence of Cl−, HOCl will diffuse through the solution and oxidize species of lower redox
potential such as SWCNTs (Fig. 4a).
Potential mechanism – do AA and GSH reduce o-SWCNTs?
During the formation of o-SWCNTs via harsh chemical oxidants, hydroxyl, carbonyl, and
carboxyl groups are generally imparted on the edges and sidewalls of nanotubes.51
Moreover, it has been demonstrated that AA52 and GSH53 can significantly reduce most
oxygen functional groups of graphene oxide resulting in a more pristine structure.
Interestingly, we observed that the D/G ratio decreased for o-SWCNTs treated with anti-
oxidants (from 0.53 for o-SWCNTs to 0.30 and 0.31 for o-SWCNTs incubated with either
AA or GSH, respectively); a similar decline in the D/G ratio was observed for CNTs that
were thermally annealed under vacuum, which results in the removal of functional groups.54
For a system consisting of reactive intermediates, HOCl, and o-SWCNTs, we would expect
the antioxidants to reduce the former two species before the SWCNTs as a consequence of
their higher redox potential (Fig. 4b). For each addition, the antioxidant was present in
higher concentration than H2O2; therefore, the excess antioxidant would be able to react
with the o-SWCNTs (Fig. 4c). Because SWCNTs with more pristine structures undergo less
efficient MPO-catalysed biodegradation,26 there exists the possibility that the antioxidants
were making the CNTs more pristine thereby mitigating biodegradation. To test this
hypothesis, o-SWCNTs that were treated with AA or GSH for four days at 37 °C were
subsequently incubated at 37 °C with MPO and H2O2 for four days in the presence and
absence of Cl−. Employing the microplate reader, it was determined that the S22 absorption
transition intensity decreased by 70% and 65% for AA and 64% and 49% for GSH at day 4
relative to day 0 in the presence and absence of Cl−, respectively (ESI†). Therefore, while it
appears that some functional groups on o-SWCNTs are reduced by antioxidants (i.e. decline
in the D/G ratio), neither AA nor GSH reduced the carboxyl groups, which are necessary for
enzyme-catalysed degradation of nanotubes.25 Thus, other mechanisms may be responsible
for the mitigation of o-SWCNT biodegradation.
Potential mechanism – effects of antioxidants on the peroxidase cycle and HOCl
Kagan et al. demonstrated that in the absence of transition metal catalysts, H2O2 fails to
oxidize AA.55 Moreover, our electron paramagnetic resonance (EPR) spectroscopy data for
a system consisting of o-SWCNTs, MPO, H2O2, and AA demonstrated the formation of the
ascorbate radical, which implies that AA is being oxidized by reactive intermediates (ESI†).
This notion is also substantiated by the redox potential of the AA (E0 = 0.066 V);56
therefore, AA has the potential to reduce Compounds I and II of MPO given that the mean
redox potentials of peroxidase cycle is 1.16 V (Fig. 4b).25 Consequently, AA can mitigate
the biodegradation of o-SWCNTs by out-competing the nano-material as a substrate for
MPO. GSH, on the other hand, is a relatively poor substrate for Compounds I and II of
MPO;57 in addition, its one-electron oxidation product, the glutathione thiyl radical, is a
strong oxidant (E0 = 0.920 V).58 However, GSH was also effective in preventing o-SWCNT
oxidation by MPO both in the presence and absence of Cl− thereby suggesting that
glutathione thiyl radical likely reacted with excess GSH in solution to form GSSG and had
not significantly contributed to the degradation of o-SWCNTs. Also, H2O2, can directly
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oxidize GSH;59 hence decreases the quantity of H2O2 available to interact with MPO and
generate reactive intermediates.
The protection afforded by the antioxidants during the production of HOCl is two-fold. First,
as described above, the antioxidants can reduce Compound I (AA) or H2O2 (GSH)thereby
reducing Compound I that is available to react with Cl−. Second, HOCl oxidizes both AA
and GSH at very rapid rates, which in turn affords protection for the o-SWCNTs (Fig. 4b).
The mechanism of AA oxidation by HOCl may entail either an electrophilic chlorination or
a two-electron-transfer reaction whereby DHA is produced.60 Meanwhile, GSH oxidation by
HOCl results in the formation of a sulphenyl chloride (GSCl), which reacts with either GSH
to produce glutathione disulphide (GSSG) or with two equivalents of HOCl thereby yielding
glutathione sulphonyl chloride (GSO2Cl).61 GSO2Cl is likely hydrolysed to glutathione
sulphonic acid (GSO2OH).61 Our ESI-MS data confirmed that both GSO2OH and GSSG
were formed.
Conclusions
The cumulative results from TEM and Raman and UV-vis absorption spectroscopies
demonstrated that both hypochlorite and reactive intermediates oxidized o-SWCNTs thereby
resulting in the degradation of this nanomaterial. Additionally, the data also established that
the water-soluble antioxidants, L-ascorbic acid and L-glutathione, could suppress MPO-
driven biodegradation of CNTs. Significantly, antioxidant supplementation may attenuate
oxidative stress-associated tissue damage incurred by CNT exposure; for example, vitamin
E deficiency enhances the pulmonary inflammatory response and oxidative stress induced
by SWCNTs in C57BL/6 mice.62 The initial phase of the inflammatory response includes
massive recruitment and activation of neutrophils (PMNs), whose MPO is involved in
biodegradation of CNTs. Therefore, the choice of protective antioxidants for regulating




Oxidized arc discharge single-walled carbon nanotubes (o-SWCNTs) were acquired from
Carbon Solutions, Inc. (P3, Riverside, CA, USA). Lyophilized purified native human
myeloperoxidase (MPO) was purchased from Athens Research and Technology, Inc.
(Athens, GA, USA). L-Ascorbic acid (AA), L-glutathione (reduced, GSH), L-glutathione
(oxidized, GSSG), hydrogen peroxide (30%, H2O2), 0.1 M phosphate buffer, sodium
chloride (NaCl), and diethylenetriaminepentaacetic acid (DTPA) were obtained from Sigma
Aldrich (St. Louis, MO, USA). Amplex Red was procured from Molecular Probes (Life
Technologies, Grand Island, NY, USA). TefSep PTFE membrane filters (GE Infrastructure
Water & Process Technologies) that were 25 mm diameter and contained a pore size of 0.22
μM were acquired from Spectrum Chemicals and Laboratory Products (New Brunswick,
NJ). Finally, sodium hydroxide (NaOH), hydrochloric acid (HCl), polystyrene 96 well plates
and Amicon Ultra 4 filters (10k MWCO, Millipore) were obtained from Fisher Scientific
(Pittsburgh, PA, USA).
Methods
DTPA was added to the 0.1 M phosphate buffer at a final concentration of 300 μM. Next, a
dispersion containing 1.0 mg mL−1 of P3 o-SWCNTs was prepared by sonicating 1.0 mL of
0.1 M/300 μM phosphate/DTPA buffer with 1.0 mg of P3 o-SWCNTs for 1 h. Stock
solutions were prepared for AA (250 mM), GSH (250 mM), H2O2 (18.75 mM), and NaCl (5
M) utilizing nanopure water as the solvent. Since the buffer in which the MPO was
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lyophilized contains NaCl, different MPO preparations were employed for −Cl− conditions.
For +Cl− samples, the as received lyophilized MPO (i.e. AR MPO) was reconstituted with
350 μL of nanopure water for a final concentration of 2.0 μM. On the other hand, for −Cl−
conditions, the lyophilized MPO was reconstituted with 350 μL of nanopure water, and the
buffer was exchanged to 0.1 M phosphate buffer utilizing an Amicon Ultra 4 to a final
volume of 350 μL (forming BE MPO). The activity of BE MPO was compared to AR MPO
utilizing Amplex Red (refer to MPO activity study, Table S2, ESI†), and the quantity of BE
MPO utilized in the experiment was proportionally adjusted to obtain equivalent rates. Table
S1 (ESI†) replicates the initial experimental conditions, which were performed in triplicate
using 96 well plates. Employing an Epoch microplate spectrophotometer (BioTek,
Winooski, VT), an initial (day 0) absorbance was measured at 999 nm. Every hour, 18.75
mM H2O2 and 250 mM of both AA and GSH were apportioned at concentrations of 75 μM,
1 mM, and 1 mM, respectively, for a total of 7 additions on day 0 and 8 additions on days 1,
2 and 3. In addition, 4 μL of AR MPO and 4.8 μL of BE MPO were added to the samples
(according to Table S1, MPO columns, ESI†) on days 1, 2 and 3. Between additions, the
samples were incubated at 37 °C in an incubator (Thermo Scientific).
On day 4 (96 h), the Epoch microplate spectrophotometer was again utilized to measure the
absorbance at 999 nm, and the samples from day 4 were characterized utilizing transmission
electron microscopy (TEM), Raman spectroscopy, and visible-near infrared (vis-NIR)
absorbance spectroscopy.
Transmission electron microscopy
Samples were diluted 1 : 100 with nanopure water. 5 μL of the suspended sample was
placed on a lacey carbon grid (Pacific-Grid Tech) and permitted to dry in ambient conditions
for overnight prior to TEM imaging (FEI Morgagni, 80 keV).
Raman spectroscopy
Samples were prepared by drop-casting approximately 100 μL of sample on a quartz
microscope slide and drying. All spectra were collected on a Renishaw inVia Raman
microscope using an excitation wavelength of 633 nm. Samples were scanned from 100 to
3100 cm−1 to visualize the RBM, D, G, and 2D bands. Spectra were collected with a 15
second exposure time and averaged across 5 scans per location; a total of 5 locations were
selected per sample.
Vis-NIR absorbance spectroscopy
Samples (150 μL) were analysed using a Lambda 900 spectrophotometer (Perkin Elmer)
and 200 μL quartz cuvettes (path length: 1 cm, World Precision Instruments, Inc.). The
samples were scanned from 500 to 1250 nm. All samples were utilized without any further
treatment or purification. Peak integration was conducted relative to the baseline employing
origin.
Electron paramagnetic resonance spectroscopy
Ascorbate radicals were detected using a JEOL-RE1X EPR spectrometer (Tokyo, Japan) in
50 mM phosphate buffer, containing 100 μM DTPA at 25 °C. Samples (100 μL) contained
3 μL SWCNT (stock concentration 5 mg mL−1), 1.5 μL MPO (stock concentration 2 μM),
100 μM H2O2, 140 mM NaCl, and 1.0 mM AA. Measurements were performed in gas-
permeable Teflon tubing (0.8 mm internal diameter, 0.013 mm thickness) from Alpha Wire
Corp. (Elizabeth, NJ). The tubing containing the sample was folded twice and placed into a
3.0 mm EPR quartz tube. The EPR conditions for detecting ascorbate radicals were: 335.0 G
centre field, 50 G sweep width, 0.79 G field modulation, 20 mW microwave power, 0.1 s
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time constant, 1000 receiver gain, 2 min time scan. Spectra were collected using EPRwase
software (Scientific Software Services, Bloomington, IL).
Electrospray ionization-mass spectrometry (ESI-MS)
Three samples, which consisted of reduced GSH (1 mg mL−1), oxidized GSH (GSSG, 1 mg
mL−1), and o-SWCNT + MPO + H2O2 + Cl− + GSH (100 μM, final) were analysed by
positive mode electrospray ionization-mass spectrometry (ESI-MS). Each sample was
filtered through a 0.22 μm syringe filter (Whatman, Sanford, ME, USA), and 1 μL of
sample was directly injected into a LCMS-2020 unit (Shimadzu Scientific, Columbia, MD,
USA). Data was acquired for 10 minutes.
Monitoring MPO activity with Amplex Red
Amplex Red was employed to test MPO activity for both the as received and buffer
exchanged MPO samples. A 10 mM stock solution of Amplex Red was prepared by
dissolving the reagent in DMSO. Table S4 (ESI†) provides the experimental details for the
assay. After gentle mixing, a fluorescence-based kinetic experiment was implemented on the
four samples whereby a Fluoromax 3 (Horiba Scientific, Edison, NJ, USA) was employed to
acquire measurements every 5 s for a total of 120 s with the excitation wavelength at 575 nm
and emission wavelength equal to 585 nm. The relative activities are compared in Fig. S6
(ESI†).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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In the presence of hydrogen peroxide (H2O2), myeloperoxidase (MPO) biodegrades
oxidized single-walled carbon nanotubes (o-SWCNTs) by two mechanisms: (1) reactive
intermediates generated via the peroxidase cycle and (2) hypochlorite produced in the
presence of chloride (Cl−). When antioxidants such as L-ascorbic acid (AA) and L-
glutathione (GSH) are added to the system, the biodegradation of o-SWCNTs is mitigated.
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Micrographs obtained by transmission electron microscopy (TEM) of o-SWCNTs dispersed
in a 0.1 M phosphate buffer (pH 7.4) with 125 nM myeloperoxidase (MPO) and 140 mM
NaCl at (a) day 0 and (b) day 4; 8 additions of H2O2 (75 μM, final) were added daily.
Micrographs of o-SWCNTs under identical conditions as (b) plus either (c) L-ascorbic acid
(AA, 1 mM per addition) or (d) L-glutathione (GSH, 1 mM per addition).
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(a) Raman spectroscopy performed on key o-SWCNTs samples (o-SWCNT: blue, o-
SWCNT + MPO + H2O2: red, o-SWCNT + MPO + H2O2 + NaCl: green, o-SWCNT +
MPO + H2O2 + NaCl + AA: violet, and o-SWCNT + MPO + H2O2 + NaCl + GSH: black)
for 4 days under experimental conditions. The radial breathing mode (RBM), D, G, and 2D
bands are identified. (b) The radial breathing mode (RBM) region of the Raman spectra. (c)
Vis-NIR absorption spectra for o-SWCNTs samples identified in (a). The inset depicts the
density of states (DOS) diagrams for metallic (left) and semiconducting (right) SWCNTs in
which the optical transitions arising from van Hove singularities. The S22 and M11
transitions are identified on the spectra. (d) The S22 absorption intensity of o-SWCNTs at
day 0 and day 4 for the given experimental conditions. This data was obtained from a
microplate reader, and the error bar represents standard error of the mean with a sample size
of three.
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With greater redox potentials, HOCl (E0 = 1.48 V) and the reactive intermediates of MPO
(E0 = 1.16 V) will oxidize (a) SWCNTs (E0 = 0.5 V) and (b) ascorbic acid (AA, E0 = 0.066
V). (c) In the absence of these oxidative species, SWCNTs can react with AA as observed
by the Raman data.
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